Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
495
NCT02305797
EDG004 Treatment of Adult Patients With Generalized Anxiety Disorder (GAD)
Phase: Phase 3
Role: Lead Sponsor
Start: Jan 31, 2015
Completion: May 31, 2016